Volatile organic metabolites identify patients with breast cancer, cyclomastopathy, and mammary gland fibroma

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Wang, Changsong ^a   Sun, Bo ^a   Guo, Lei ^a   Wang, Xiaoyang ^a   Ke, Chaofu ^a   Liu, Shanshan ^a   Zhao, Wei ^a   Luo, Suqi ^a   Guo, Zhigang ^a   Zhang, Yang ^a   Xu, Guowang ^b   Li, Enyou ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; VOLATILE ORGANIC COMPOUND;

ADULT; BREAST NEOPLASMS; BREATH ANALYSIS; FEMALE; FIBROMA; HUMAN; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; BIOMARKERS, TUMOR; BREAST NEOPLASMS; BREATH TESTS; CARCINOMA, DUCTAL, BREAST; FEMALE; FIBROMA; HUMANS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VOLATILE ORGANIC COMPOUNDS;

EID: 84903160331     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05383     Document Type: Article

References (40)

1. Benson, J. R. & Jatoi, I. The global breast cancer burden. Future Oncol. 8, 697-702 (2012).
2. Siege, L. R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA. Cancer J. Clin. 62, 10-29 (2012).
3. Tabár, L., Vitak, B. & Chen, H. H. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin. North Am. 38, 625-651 (2000). (Pubitemid 30640056)
4. Nyström, L., Rutqvist, L. E. & Wall, S. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 341, 973-978 (1993). (Pubitemid 23109165)
5. Humphrey, L. L., Helfand, M. & Chan, B. K. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern Med. 137, 347-360 (2002). (Pubitemid 34977137)
6. Tabár, L., Fagerberg, C. J. & Gad, A. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1, 829-32 (1985).
7. Nystrom, L., Anderson, I. & Bjurstam, N. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lanct. 359, 909-919 (2002). (Pubitemid 34246378)
8. Pisano, E. D. et al. Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N. Engl. J. Med. 353, 1773-1783 (2005). (Pubitemid 41549889)
9. Zonderland, H. M., Coerkamp, E. G., Hermans, J., Vijver, M. J. & Voorthuisen, A. E. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology. 213,413-422 (1999). (Pubitemid 29510587)
10. Skaane, P. The additional value of US to mammography in the diagnosis of breast cancer. A prospective study. Acta. Radiol. 40, 486-490 (1999). (Pubitemid 129567259)
11. Nemec, C. F., Listinsky, J. & Rim, A. How should we screen for breast cancer? Mammography, ultrasonography, MRI. Cleve. Clin. J. Med. 12, 897-904 (2007).
12. Akazawa, K. et al. Preoperative evaluation of residual tumor extent by threedimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy. Breast J. 12, 130-137 (2006).
13. Blair, S. et al. The efficacy of breast MRI in predicting breast conservation therapy. J. Surg. Oncol. 94, 220-225 (2006). (Pubitemid 44289986)
14. Song, G. et al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer. 67, 227-231 (2010).
15. Peng, G. et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer. 103, 542-551 (2010).
16. Poli, D. et al. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. J. Chromatogr B. Analyt. Technol. Biomed Life Sci. 878, 2643-2651 (2010).
17. Phillips, M. et al. Volatile biomarkers in the breath of women with breast cancer. J Breath Res. 4, 026003 (2010).
18. Patterson, S. G. et al. Breath analysis by mass spectrometry: a new tool for breast cancer detection? Am. Surg. 77, 747-751 (2011).
19. Shuster, G. et al. Classification of breast cancer precursors through exhaled breath. Breast. 126, 791-796 (2011).
20. Phillips, M. Volatile markers of breast cancer in the breath. Breast J. 9, 184-191 (2003). (Pubitemid 36627163)
21. Kneepkens, C. M., Ferreira, C., Lepage, G. & Roy, C. C. The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. Clin. Invest. Med. 15, 163-186 (1992).
22. Barash, O. et al. Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine. 8, 580-589 (2012).
23. Chen, X. et al. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer. 110, 835-844 (2007). (Pubitemid 47257662)
24. Knight, J. A. Free radicals: their history, and current status in aging and disease. Ann. Clin. Lab. Sci. 28, 331-346 (1998). (Pubitemid 28541691)
25. Phillips, M. et al. Volatile biomarkers in the breath of women with breast cancer. J. Breath Res. 4, 026003 (2010).
26. Subramanian, A., Salhab, M. & Mokbel, K. Oestrogen producing enzymes and mammary carcinogenesis: a review. Breast Cancer Res. Treat. 111, 191-202 (2008).
27. Richards, J. A., Petrel, T. A. & Brueggemeier, R. W. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. J. Steroid Biochem. Mol. Biol. 80, 203-212 (2002). (Pubitemid 34233740)
28. Chen, S. Aromatase and breast cancer. Front Biosci. 3, 922-933 (1998).
29. Arun, B. & Goss, P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin. Oncol. 31, 22-29 (2004). (Pubitemid 38879411)
30. Jongen, V. H.,Hollema, H., Zee, A. G.&Heineman, M. J. Aromatase in the context of breast and endometrial cancer.Areview. Minerva Endocrinol. 31, 47-60 (2006).
31. Hannemann, F., Bichet, A., Ewen, K. M. & Bernhardt, R. Cytochrome P450 systems-biological variations of electron transport chains Biochim. Biophys. Acta. 1770, 330-344 (2007). (Pubitemid 46157074)
32. Kneepkens, C. M., Lepage, G. & Roy, C. C. The potential of the hydrocarbon breath test as a measure of lipid peroxidation Free Radic. Biol. Med. 17, 127-160 (1994). (Pubitemid 24217183)
33. Spink, D. C. et al. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase. J. Steroid Biochem. Mol. Biol. 51, 251-258 (1994).
34. Liehr, J. G. & Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad Sci. USA. 93, 3294-3296 (1996). (Pubitemid 26125612)
35. Phillips, M. et al. Gunawardena R. Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. J. Lab Clin. Med. 136, 243-249 (2000).
36. Birken, T., Schubert, J., Miekisch, W. & Noldge-Schomburg, G. A novel visually CO2 controlled alveolar breath sampling technique. Technol. Health Care. 14, 499-506 (2006). (Pubitemid 44885294)
37. Miekisch, W. et al. Impact of sampling procedures on the results of breath analysis. J. Breath Res. 2, 026007 (2008).
38. Bajtarevic, A. et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC. Cancer. 9, 348 (2009).
39. Lin, H. M., Edmunds, S. I., Helsby, N. A., Ferguson, L. R. & Rowan, D. D. Nontargeted urinary metabolite profiling of a mouse model of Crohn's disease. J. Proteome Res. 8, 2045-2057 (2009).
40. Gao, X. et al. Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal. Biochem. 393, 163-175 (2009).